Ads
related to: lung cancer brain metastases treatment options chart for seniors- 2L mNSCLC Treatment
For Metastatic
NSCLC. Visit Physician Site.
- mNSCLC Biomarker Info
Discover A Treatment For 2L mNSCLC
With This Actionable Biomarker
- Efficacy & Safety Data
See If A 2L mNSCLC Treatment
Is An Option For Your Patients.
- Mechanism Of Action Info
See How A 2L Metastatic
NSCLC Therapy Works.
- Resources For Physicians
Downloadable Resources For Your
mNSCLC Patients & Their Caregivers.
- Dosing & Administration
View Dosing & Preparation Info For
A 2L mNSCLC Treatment Option.
- 2L mNSCLC Treatment
Search results
Results From The WOW.Com Content Network
In 2016, the FDA approved atezolizumab for the treatment of people with metastatic non-small cell lung cancer (NSCLC) whose disease progressed during or following platinum-containing chemotherapy and pembrolizumab for the treatment of people with metastatic non-small cell lung cancer (NSCLC) whose tumors express programmed death-ligand 1 as ...
The majority of drugs used in cancer chemotherapy are cytostatic, many via cytotoxicity. A fundamental philosophy of medical oncology , including combination chemotherapy, is that different drugs work through different mechanisms, and that the results of using multiple drugs will be synergistic to some extent.
A theory was developed that the brain was likely a pharmacologic sanctuary where sub-clinical metastases were protected from cytotoxic drugs by the blood–brain barrier. Oncologists hypothesized that treatment of this sub-clinical disease with radiation therapy may stamp out the malignant process before it could advance to cause symptoms.
A brain metastasis is a cancer that has metastasized (spread) to the brain from another location in the body and is therefore considered a secondary brain tumor. [ 1 ] [ 2 ] The metastasis typically shares a cancer cell type with the original site of the cancer. [ 3 ]
Diagnostic techniques for CNS metastasis are a major area of ongoing research, as detecting metastatic lesions early is crucial for timely treatment and better patient outcomes. [ 14 ] One promising field is the use of biomarkers - proteins, genes, or other molecules associated with a specific condition.
Pie chart showing incidence of large-cell lung cancer (shown in green at upper left) as compared to other lung cancer types, with fractions of smokers versus non-smokers shown for each type. [ 7 ] In most series, LCLC's comprise between 3%-9% of all primary lung cancers .
Ads
related to: lung cancer brain metastases treatment options chart for seniors